Cy3 Goat Anti-Human IgG (H+L) Antibody: Fluorescent Benchmark for Human Immunoglobulin Detection

Executive Summary: The Cy3 Goat Anti-Human IgG (H+L) Antibody (SKU: K1208, APExBIO) is a polyclonal secondary antibody designed for the detection of human immunoglobulins. It is conjugated with Cy3, a fluorophore with excitation at 552 nm and emission at 565 nm, enabling robust signal amplification in immunoassays (APExBIO product page). The antibody is affinity-purified and validated for immunofluorescence, IHC (frozen/paraffin), flow cytometry, and ELISA. It enables reproducible, sensitive detection of human IgG through multiple secondary antibody binding events (Cy3 Goat Anti-Human IgG: Fluorescent Benchmarks). The reagent is stable for 12 months at -20°C if protected from light. These claims are grounded in peer-reviewed studies of secondary antibody performance and referenced product documentation (Zhao et al. 2025).

Biological Rationale

Human immunoglobulin G (IgG) is the most abundant immunoglobulin in serum and is a key target in immunological research and diagnostics. Secondary antibodies, such as the Cy3 Goat Anti-Human IgG (H+L) Antibody, are essential tools for amplifying detection signals and increasing assay sensitivity. The use of secondary antibodies labeled with stable fluorophores enables multiplexing and precise quantification (Zhao et al. 2025). Polyclonal antibodies, generated by immunizing goats with pooled human IgG, provide broad epitope recognition, increasing the robustness of detection across diverse clinical and research samples (APExBIO).

Mechanism of Action of Cy3 Goat Anti-Human IgG (H+L) Antibody

The Cy3 Goat Anti-Human IgG (H+L) Antibody operates as an affinity-purified polyclonal secondary antibody. It specifically binds to both heavy (γ) and light (κ, λ) chains of human IgG molecules. The Cy3 fluorophore is covalently linked to the antibody, allowing excitation at 552 nm and emission at 565 nm for detection by fluorescence readers or microscopes. In immunoassays, the antibody binds to the Fc or Fab regions of primary human IgG, enabling visualization or quantification of antigen-antibody complexes. This results in signal amplification, as multiple secondary antibodies can bind to a single primary antibody, thereby increasing fluorescent output and detection sensitivity (Optimizing Human IgG Detection: Cy3 Goat Anti-Human IgG; extends previous mechanistic reviews by detailing Cy3-specific signal amplification).

Evidence & Benchmarks

• Affinity-purified polyclonal antibodies show increased sensitivity and lower cross-reactivity in human IgG detection compared to crude serum or non-affinity-purified preparations (Zhao et al. 2025).
• Cy3-conjugated secondary antibodies provide a linear detection range of 10–1,000 ng/mL human IgG in direct immunofluorescence under standard assay conditions (PBS, pH 7.4, 23°C, 30 min incubation) (Cy3 Goat Anti-Human IgG: Fluorescent Benchmarks).
• Multiple secondary antibody binding sites enable up to 10-fold signal amplification in ELISA and immunofluorescence, improving limit of detection (LOD) to <2 ng/mL human IgG in optimized systems (Illuminating Precision in Human IgG Detection).
• The K1208 antibody retains >90% fluorescence intensity after 12 months at −20°C in 23% glycerol/PBS/1% BSA/0.02% sodium azide, provided light exposure is minimized (APExBIO).
• Validated for immunocytochemistry (ICC/IF), immunohistochemistry on frozen and paraffin sections, flow cytometry, and ELISA; not compatible with denatured/reduced IgG targets (Strategic Innovation in Human IgG Detection).

Applications, Limits & Misconceptions

The Cy3 Goat Anti-Human IgG (H+L) Antibody is suitable for:

• Immunocytochemistry (ICC) and immunofluorescence (IF) for localizing human IgG in cultured cells and tissues.
• Immunohistochemistry (IHC) on frozen and paraffin-embedded tissue sections.
• Flow cytometry for quantitative measurement of cell-bound or serum IgG.
• Enzyme-linked immunosorbent assay (ELISA) for quantitative and high-throughput IgG detection.

Limitations:

• Not recommended for detection of denatured or reduced human IgG, as epitope conformation may be lost.
• Cy3 fluorescence is susceptible to photobleaching; samples should be protected from prolonged light exposure.
• Potential cross-reactivity with non-human primate IgG due to conserved epitopes.
• Performance may decline in presence of high concentrations of other serum proteins or in heavily fixed specimens.

Common Pitfalls or Misconceptions

• Myth: Cy3 Goat Anti-Human IgG (H+L) Antibody is suitable for all species. Fact: It is optimized for human IgG; cross-reactivity with other species is possible but not validated (APExBIO).
• Myth: The antibody can detect denatured or reduced IgG. Fact: Detection relies on intact epitopes; denaturation can abrogate binding.
• Myth: Cy3 fluorescence is permanent. Fact: Cy3 is prone to photobleaching; handle samples in the dark.
• Myth: Storage at room temperature is acceptable. Fact: The product should be stored at 4°C short-term or −20°C for long-term stability.
• Myth: All secondary antibodies provide equivalent sensitivity. Fact: Affinity purification and fluorophore conjugation substantially enhance sensitivity and specificity (Zhao et al. 2025).

Workflow Integration & Parameters

For optimal results, the Cy3 Goat Anti-Human IgG (H+L) Antibody should be diluted to a working concentration of 1–10 μg/mL in PBS with 1% BSA. Incubation should proceed for 30–60 minutes at room temperature (23°C). Wash steps using PBS reduce background. Samples should be mounted using anti-fade reagents and stored in darkness. For flow cytometry, compensation controls should be established due to Cy3 spectral overlap with other fluorophores. The antibody is supplied at 1 mg/mL in a buffer of 23% glycerol, PBS, 1% BSA, and 0.02% sodium azide. Shipping is at 4°C; for long-term storage, aliquot and freeze at −20°C. Avoid repeated freeze-thaw cycles. For detailed scenario-based optimization, see Optimizing Human IgG Detection: Cy3 Goat Anti-Human IgG (this article expands on specific integration parameters compared to general workflow guides).

Conclusion & Outlook

The Cy3 Goat Anti-Human IgG (H+L) Antibody (APExBIO) is a validated, high-sensitivity reagent for the detection of human immunoglobulins in a range of immunoassays. Its robust performance, reproducibility, and compatibility with ICC, IHC, flow cytometry, and ELISA make it a benchmark tool for both translational and basic research. Ongoing advances in antibody engineering and fluorophore chemistry are expected to further enhance specificity and multiplexing capabilities (Zhao et al. 2025). For expanded discussion on mechanistic innovation and next-generation assay design, see Strategic Innovation in Human IgG Detection (this article clarifies molecular and translational context with new evidence).

For product details and technical documentation, visit the Cy3 Goat Anti-Human IgG (H+L) Antibody product page.